Paroxysmal Nocturnal Haemoglobinuria
📧 Sign up to get email alerts when something new happens for Paroxysmal Nocturnal Haemoglobinuria.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2024-03-22First oral monotherapy for patients with paroxysmal nocturnal haemoglobinuria
EMA has recommended EU marketing authorization for Fabhalta (iptacopan), an oral monotherapy for adults with paroxysmal nocturnal haemoglobi…
-
EMA approval · 2024-02-23First oral treatment against residual haemolytic anaemia in patients with paroxysmal nocturnal haemoglobinuria
EMA recommends marketing authorization for Voydeya, the first oral treatment for Paroxysmal nocturnal haemoglobinuria patients with residual…